Sergey discusses the groundbreaking potential of gene editing and therapies to drastically reduce healthcare costs, emphasizing the excitement surrounding these advancements. However, both he and James reflect on the ethical and regulatory challenges of self-experimentation, highlighting the complexity of gene interactions and the risks involved. The conversation underscores the need for patience as safer, more affordable solutions are on the horizon.
